Pharmacological treatment of COVID-19

The clinical data available on COVID-19 and the research carried out to date have generated an extensive list of drugs that could potentially be used or are already being used Different therapeutic targets have been proposed to combat the disease;According to this, we can speak of antiviral agents, when they act on the microorganism itself;or immunosuppressants and immunomodulators, when the treatment objective is preventing or treating the inflammation generated as a consequence of this infection At this time, there are only two drugs that have shown an effect in clinical trials, the antiviral remdesivir and systemic corticosteroid treatment However, only systemic corticosteroids have shown to improve the prognosis of the disease It is a priority to continue conducting controlled and quality clinical trials, which will provide us with answers to the many questions that have been generated throughout this pandemic Pending more scientific evidence, it is recommended to follow the clinical management protocols established by each health care center